Telangiectasias, also known as spider veins, are dilated superficial veins of the skin with a diameter of up to 1 mm. They often appear as bluish or reddish lines arranged in a spider-web or star-like pattern.

Reticular veins are dilated veins located slightly deeper, at the junction between the skin and subcutaneous tissue. They often form a branching network and are approximately 1 to 3 millimetres in diameter.

Both types of veins most commonly appear on the outer thighs, lower legs and in the popliteal region (the back of the knee). In most cases, they have very little or no effect on venous haemodynamics.

Reticular veins of the legs may cause symptoms such as a feeling of heaviness, stabbing pain or pressure in the legs, while telangiectasias are generally asymptomatic.

It is important to distinguish reticular veins and telangiectasias (CEAP stage C1) from varicose veins (CEAP stage C2).

Diagnosis is established through a thorough examination of the venous system, targeted questions regarding the patient’s medical history and clinical examination using the Veinlite LEDX, a portable transilluminator specifically designed to facilitate microsclerotherapy. Ideally, an ultrasound examination of the veins is also performed. Ultrasound is used to rule out abnormalities of the deep venous system, as well as reflux at the saphenofemoral junction located in the groin or at the saphenopopliteal junction located in the popliteal fossa behind the knee.

After the diagnosis has been established, a treatment plan is agreed upon together with the patient. It is important to note that remodelling of the treated veins occurs over several weeks and that several treatment sessions may be required to achieve the desired effect.

Injection of a sclerosing agent (Aethoxysklerol) into a vein is called sclerotherapy. Sclerotherapy of reticular veins and telangiectasias is called microsclerotherapy, which is also the treatment of choice for these conditions. Treatment of varicose veins with this type of sclerotherapy is not recommended.

When the sclerosing agent is injected into the vein, the blood is displaced and the agent subsequently damages the venous endothelium, which is the inner lining of the vein wall. This leads to closure of the vein, which over time is transformed into scar tissue that can no longer carry blood. Shortly after the initial blanching of the vein caused by the injection of Aethoxysklerol, the treated area may become mildly red. This is one of the signs of inflammation and represents an expected and normal effect of the sclerosing agent on the vein wall.

We use Aethoxysklerol in concentrations of 0.25%, 0.5% or 1%, in either liquid or foam form, depending on the type and characteristics of the vein being treated.

After treatment, local compression is applied using gauze or a dressing pad, followed by an elastic compression stocking. The stocking should be worn continuously for 24 hours and then for an additional two to seven days for at least 8 hours per day. Walking for approximately 15 to 30 minutes immediately after the procedure is recommended.

The main restrictions after treatment include avoiding saunas, tanning beds and sunbathing. Prolonged sitting and standing should also be avoided where possible, while other normal daily activities can generally be continued.

Complications are usually temporary and may resolve within one year. These may include microthromboses (dark blue or black spots), hyperpigmentation (darkening of the skin at the treatment site) and matting, which is the appearance of new small telangiectasias as a reaction to the sclerosing agent. Matting occurs in fewer than 5% of treatments and can be treated with laser therapy, while further sclerotherapy is discontinued.

The first follow-up examination is usually performed after one to two weeks, when any microthromboses may be removed if necessary. The second follow-up examination is performed after approximately six weeks, when the final effect of the treatment can be assessed.

Written by Dr Frano Šimić, Specialist in Vascular Surgery

Split, 25 November 2019

The content published on these pages is protected under the Copyright Act of the Republic of Croatia and may not be used or reproduced without the written permission of the author. | 2019. © Aqua Med Medical Wellness – all rights reserved.